Cantor Fitzgerald Maintains a Buy Rating on Crinetics Pharmaceuticals (CRNX)

Oct 9, 2025 - 05:00

1

Cantor Fitzgerald Maintains a Buy Rating on Crinetics Pharmaceuticals (CRNX)

Related Posts

ZipRecruiter president David Travers sells $106,161 in stock

ZipRecruiter president David Travers sells $106,161 in ...

Mar 21, 2025 0

DOGE says IRS modernization program is $15B over budget and 30 years overdue

DOGE says IRS modernization program is $15B over budget...

Mar 21, 2025 2

Meta global affairs chief says decision not to offer Instagram, Facebook in China helps defend free expression

Meta global affairs chief says decision not to offer In...

Mar 21, 2025 3

Elon Musk reassures Tesla workers with all-hands meeting, admits it 'feels like Armageddon'

Elon Musk reassures Tesla workers with all-hands meetin...

Mar 21, 2025 3

Argentina suspends Telecom's purchase of Telefonica unit

Argentina suspends Telecom's purchase of Telefonica unit

Mar 21, 2025 2

Businesses may have to pass high beef prices on to consumers

Businesses may have to pass high beef prices on to cons...

Mar 21, 2025 0